Wolfgang Kranewitter
Overview
Explore the profile of Wolfgang Kranewitter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Strasser B, Kranewitter W, Hofer H, Haushofer A
Lab Med
. 2024 Mar;
55(5):655-657.
PMID: 38530637
A 46-year-old male patient presented with inflammatory diseases over more than 3 years. The patient suffered from recurrent pleuritis, polychondritis, orbital phlegmon, fever, and skin lesions. A bone marrow puncture...
2.
Montero-Lopez R, Laurer E, Tischlinger K, Nagy D, Scala M, Kranewitter W, et al.
Bone Rep
. 2022 Jun;
16:101595.
PMID: 35693066
Background: Vertebral compression fractures (VFs) are a common and severe finding in patients with osteoporosis. In children, VFs have the unique potential to reshape and regain their original configuration. Spontaneous...
3.
Thiem U, Buxhofer-Ausch V, Kranewitter W, Webersinke G, Enkner W, Cejka D
Am J Transplant
. 2020 Jul;
21(1):405-409.
PMID: 32654389
Active malignancy is an absolute contraindication to kidney transplantation. As for chronic myeloid leukemia (CML), a Philadelphia chromosome-positive myeloproliferative neoplasm, the introduction of tyrosine kinase inhibitors has transformed CML from...
4.
Obermair F, Rammer M, Burghofer J, Malli T, Schossig A, Wimmer K, et al.
Fam Cancer
. 2018 Oct;
18(2):253-260.
PMID: 30306390
Hereditary diffuse gastric cancer (HDGC) is an autosomal-dominantly inherited cancer syndrome associated with a high risk for diffuse gastric and lobular breast cancer, caused by heterozygous CDH1 germline mutations. Of...
5.
Malli T, Rammer M, Haslinger S, Burghofer J, Burgstaller S, Boesmueller H, et al.
Mol Cytogenet
. 2018 Jan;
11:3.
PMID: 29344090
Background: Translocations of the locus on 14q32.3 are present in about 8% of patients with chronic lymphocytic leukemia (CLL) and contribute to leukemogenesis by deregulating the expression of the -partner...
6.
Malli T, Buxhofer-Ausch V, Rammer M, Erdel M, Kranewitter W, Rumpold H, et al.
Genes Chromosomes Cancer
. 2015 Sep;
55(1):60-8.
PMID: 26391436
Myeloid and lymphoid neoplasms with fibroblast growth factor receptor 1 (FGFR1) abnormalities, also known as 8p11 myeloproliferative syndrome (EMS), represent rare and aggressive disorders, associated with chromosomal aberrations that lead...
7.
Malli T, Duba H, Erdel M, Marschon R, Kranewitter W, Deutschbauer S, et al.
Am J Med Genet A
. 2014 Sep;
164A(12):3126-31.
PMID: 25250687
Here, we report on a male patient with developmental delay, speech impairment, mild dysmorphic features, and borderline intellectual disability, bearing a de novo balanced t(5;6)(q11;q25.3). By combining FISH and long...
8.
Bosmuller H, Kranewitter W, Webersinke G, Rumpold H, Hackl M, Fend F
Pathol Res Pract
. 2011 May;
207(6):399-402.
PMID: 21536390
Approximately forty percent of colorectal cancers (CRC) are characterized by activating mutations of the K-RAS gene. Determination of K-RAS mutational status as a predictive marker for anti-EGFR therapy is usually...
9.
Kralik J, Kranewitter W, Boesmueller H, Marschon R, Tschurtschenthaler G, Rumpold H, et al.
Diagn Pathol
. 2011 Mar;
6:19.
PMID: 21401966
Background: Characterization of novel fusion genes in acute leukemia is important for gaining information about leukemia genesis. We describe the characterization of a new ETV6 fusion gene in acute myeloid...
10.
Aschl G, Kirchgatterer A, Fleischer M, Hinterreiter M, Hubner D, Kranewitter W, et al.
Wien Klin Wochenschr
. 2008 May;
120(7-8):224-7.
PMID: 18500597
Background: Percutaneous endoscopic gastrostomy (PEG) is the method of choice for long- term artificial enteral feeding. Standardized wound management such as daily dressing changes and local disinfection of the exit...